WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032144) DRY POWDER COMPOSITIONS HAVING IMPROVED DISPERSIVITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032144    International Application No.:    PCT/US2000/009785
Publication Date: 10.05.2001 International Filing Date: 12.04.2000
Chapter 2 Demand Filed:    28.05.2001    
IPC:
A61K 47/18 (2006.01)
Applicants: INHALE THERAPEUTIC SYSTEMS, INC. [US/US]; 150 Industrial Road, San Carlos, CA 94070 (US) (For All Designated States Except US).
LECHUGA-BALLESTEROS, David [MX/US]; (US) (For US Only).
KUO, Mei-Chang [US/US]; (US) (For US Only)
Inventors: LECHUGA-BALLESTEROS, David; (US).
KUO, Mei-Chang; (US)
Agent: EVANS, Susan, T.; Inhale Therapeutic Systems, Inc., 150 Industrial Road, San Carlos, CA 94070 (US)
Priority Data:
60/162,451 29.10.1999 US
60/164,236 08.11.1999 US
60/172,769 20.12.1999 US
60/178,383 27.01.2000 US
60/178,415 27.01.2000 US
Title (EN) DRY POWDER COMPOSITIONS HAVING IMPROVED DISPERSIVITY
(FR) COMPOSITIONS DE POUDRE SECHE A DISPERSIVITE AMELIOREE
Abstract: front page image
(EN)The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject.
(FR)La présente invention concerne une formulation hautement dispersable contenant un agent actif et un dipeptide ou un tripeptide comprenant au moins deux résidus leucyl. La composition de l'invention présente des propriétés aérosol supérieures et par conséquent on la préconise pour une administration en aérosol dans les poumons. En outre, cette invention concerne un procédé pour: (a) augmenter la dispersabilité d'une formulation contenant un agent actif pour l'administrer aux poumons, et (b) administrer la composition aux poumons du sujet.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)